StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) stock

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302571% above fair value
$403.60−9.66 (-2.34%)

Close on Nov 18, 2026Market cap $45.89BP/E 72.2Yield –

BeOne Medicines pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

BeOne Medicines's pe ratio was 75.1× on Nov 11, 2026, against 873.4× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202675.1×−703.9
2025Dec 31, 2025779.0×–

More BeOne Medicines figures

See a number that looks wrong?